Ben Schilling

Ben Schilling

About

Detail

VP, Fp&a
Mansfield, Massachusetts, United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Sanofi
    Principle Device Engineer
    Sanofi
    Sep 2025 - Current (1 year)
  • Vertex Pharmaceuticals
    Senior Manager
    Vertex Pharmaceuticals
    Aug 2024 - Aug 2025 (1 year 1 month)
  • Vertex Pharmaceuticals
    Principal Scientist, Translational Engineering
    Vertex Pharmaceuticals
    May 2021 - Mar 2025 (3 years 11 months)
  • University of Pittsburgh
    Graduate Student Researcher
    University of Pittsburgh
    Aug 2016 - May 2021 (4 years 10 months)
    Dissertation: “Mechanization and assessment of regenerative therapies for peripheral nerve injury and the associated muscle atrophy”, Summarized in Education Section below. Description of selected projects beyond dissertation work: Design of Individual Biocontainment Unit for mitigation of COVID-19: Collaborated with cross-functional team of doctors (Emergency Medicine, Plastic Surgical) and engineers to design, fabricate, and test a rapidly-deployable negative pressure system capable mitigating infection risks from COVID-19 in emergency care via >99.997% air particle reduction. Submitted device to US FDA for Emergency Use Authorization (EUA), leading authorship of Instructions for Use and Instructions for Healthcare Professionals includi
  • M
    Engineer
    Musculoskeletal Transplant Foundation
    Jun 2012 - Aug 2016 (4 years 3 months)
    Designed and optimized decellularization, disinfection and lyophilization processes for adipose tissue matrix based on ability to obtain maximal yields from tissue donations. Participated in opportunity assessment and design review with surgeon consultants to engineer regenerative, injectable allografts. Optimized and conducted biochemical and physical analyses to determine most efficacious iteration of process and end product based on user requirements. Created process for a new tissue form to identify an opportunity to increase product yields while decreasing waste using excess allograft material resulting from current manufacturing process. Prepared samples aseptically for analysis of in vivo performance via animal study. Worked closely
  • M
    Research Associate - Co-Op
    Musculoskeletal Transplant Foundation
    Jun 2011 - Jan 2012 (8 months)
    Performed data analyses translating to Technical Sales Literature for Marketing Department and for decision-making on current and new product opportunities. Responsible for competitive analysis to benchmark MTF dermal tissue, FlexHD, against other commercial products by tensile and elasticity testing, growth factor analyses, and processing residuals investigations.
  • TRIMEDX
    Intern
    TRIMEDX
    Dec 2009 - Jan 2010 (2 months)
    Improved upon previous knowledge of important concepts in medical device functionality and preventative maintenance. Engaged in concepts and methods in hematology, histology, microbiology, and pathology. Assisted in the grossing process of specimens to better understand the physiology that is relevant to pathology.
  • Rensselaer Polytechnic Institute
    Laboratory Researcher
    Rensselaer Polytechnic Institute
    Sep 2009 - May 2010 (9 months)
    Removal of Soluble Factors from Neural Stem Cells Produced a microfluidics device to remove soluble factors from neural stem cells in hopes of observing altered patterns of differentiation. A prototype device was created and research continued by the overseeing graduate student. Cryopreservation of Neural Stem Cells Studies consisted of freezing Neural Stem Cells (NSC) and comparing proliferation relative to non-frozen NSCs. Research emphasized the usage of microscopy for cell counting, cell culture, media formulation, staining, and the extraction of mouse encephalons for stem cells harvesting.
Education verified_user 0% verified
  • University of Pittsburgh
    Doctor of Philosophy - PhD, Bioengineering and Biomedical Engineering
    University of Pittsburgh
    Jan 2017 - Jan 2021 (4 years 1 month)
    Dissertation focused on regenerative therapies for recovering muscle strength after denervation injury with specific emphasis on automation and repeatability when producing regenerative therapies. Designed and developed hardware and software (LabVIEW) of a perfusion bioreactor system capable of automated decellularization of porcine and rodent skeletal muscle, reducing the rate of the decellularization process from seven days on agitation to one day (publication in Tissue Engineering: Part A). Designed and fabricated an automated mechanism for creating drug eluting microsphere-embedded polymer conduits for nerve repair significantly reducing process time and variability (patent pending). Investigated injections of Nanofat, and skeletal musc
  • University of Pittsburgh
    Master's degree, Medical Product Engineering
    University of Pittsburgh
    Jan 2016 - Jan 2017 (1 year 1 month)
    From the website: "Pitt’s Professional MS in Medical Product Engineering (MS-MPE) program applies engineering innovation to the identification of and solution to challenges in health care delivery in the medical industry. Students have the opportunity to work with the renowned University of Pittsburgh Medical Center in a city that has been named a U.S. tech hub to watch.The program is offered by Pitt’s nationally ranked Department of Bioengineering ( #12, U.S. News and World Report) in conjunction with the University of Pittsburgh Center for Medical Innovation (CMI). We offer hands-on, practical experience in medical product design and development that will prepare you for an industrial or academic career in the medical product engineering
  • Rensselaer Polytechnic Institute
    BS, Biomedical Engineering
    Rensselaer Polytechnic Institute
    Jan 2008 - Jan 2012 (4 years 1 month)
    Degree Concentration in Materials
  • B
    Broadalbin-Perth HS
    BroadalbinPerth HS
    Jan 2004 - Jan 2008 (4 years 1 month)
Publications verified_user 0% verified
  • P
    The Impact of Plastic Surgery Training on Family Planning and Prenatal Health
    Plastic Reconstructive Surgery Nov
    Authors: DA Bourne; W Chen; BK Schilling; E Littleton; KM Washington; C De La Cruz Background: Plastic surgery trainees who wish to start a family face challenges. This is the first study to collect data directly from residents and fellows to understand issues surrounding childbearing and to propose solutions. Methods: Following institutional review board approval, an anonymous survey was distributed to all current plastic surgery residents and fellows in the United States. Data regarding demographics, obstetrical complications, parental leave, breastfeeding, and use of assisted reproductive technology were collected. Results: The survey was completed by 307 trainees, for a resident response rate of 27.0 percent. Mean age of the responde
  • P
    A Report of Gender Bias and Sexual Harassment in Current Plastic Surgery Training: A National Survey
    Plastic Reconstructive Surgery Jun
    Background: Gender bias and sexual misconduct continue to pervade medicine. The authors hypothesize that gender bias and sexual misconduct disproportionately and negatively affect female plastic surgery trainees. Methods: A national survey of plastic surgery trainees (2018-19) was conducted using previously validated sexual harassment surveys adapted for relevance. Respondents were queried about experiences with workplace gender bias and harassment; personal and professional impact; and reporting practices. Analyses included chi-square, logistic regression, and ANOVA. Significance was accepted for values of p<0.05. Results: There were 236 responses (115 female; 20.1% response rate). Most respondents were Caucasian residents (n=123). The f
  • J
    The Future of Microsurgery: Vascularized Composite Allotransplantation and Engineering Vascularized Tissue
    Journal of Hand and Microsurgery Apr
    Authors: FM Egro, BK Schilling, JD Fisher, R Saadoun, JP Rubin, KG Marra, MG Solari Abstract: Background: Microsurgical techniques have revolutionized the field of reconstructive surgery and are the mainstay for complex soft tissue reconstruction. However, their limitations have promoted the development of viable alternatives. This article seeks to explore technologies that have the potential of revolutionizing microsurgical reconstruction as it is currently known, reflect on current and future vascularized composite allotransplantation (VCA) practices, as well as describe the basic science within emerging technologies and their potential translational applications. Methods: A literature review was performed of the technologies that may
  • P
    Injectable Allograft Adipose Matrix Promotes Adipogenic Tissue Remodeling in the Nude Mouse and Human
    Plastic Reconstructive Surgery Jan
    Authors: LE Kokai, BK Schilling, E Chnari, YC Huang, E Imming, A Karunamurthy, R Khouri, R D’Amico, KG Marra, JP Rubin Background: Adipose tissue reaches cellular stasis after puberty, leaving adipocytes unable to significantly expand or renew under normal physiologic conditions. This is problematic in progressive lipodystrophies, in instances of scarring, and in soft-tissue damage. Methods: A process comprising separate steps of removing lipid and cellular materials from adipose tissue has been developed, creating an ambient temperature-stable allograft adipose matrix. Growth factors and matrix proteins relevant to angiogenesis and adipogenesis were identified by enzyme-linked immunosorbent assay and immunohistochemistry, and subcutaneo
  • S
    Long-Gap Peripheral Nerve Repair Through Sustained Release of a Neurotrophic Factor in Non-human Primates
    Science Translational Medicine Jan
    Severe injuries to peripheral nerves are challenging to repair. Standard-of-care treatment for nerve gaps >2 to 3 centimeters is autografting; however, autografting can result in neuroma formation, loss of sensory function at the donor site, and increased operative time. To address the need for a synthetic nerve conduit to treat large nerve gaps, we investigated a biodegradable poly(caprolactone) (PCL) conduit with embedded double-walled polymeric microspheres encapsulating glial cell line–derived neurotrophic factor (GDNF) capable of providing a sustained release of GDNF for >50 days in a 5-centimeter nerve defect in a rhesus macaque model. The GDNF-eluting conduit (PCL/GDNF) was compared to a median nerve autograft and a PCL conduit conta
  • E
    Adipose Tissue-Derived Stem Cells: Sources and Therapeutic Applications
    Elsevier Encyclopedia of Tissue Engineering and Regenerative Medicine
    Authors: BK Schilling & KG Marra Since their discovery and characterization, adipose-derived stem cells (ASC) have shown exceptional potential for regenerative clinical therapies. Recent investigations have advanced the knowledge of their pluripotent differentiation pathways in vitro, and have provided new insights into the mechanisms by which ASCs communicate within their microenvironment in vivo. Their secretory paracrine and trophic factors have gained considerable traction as key mediators, particularly in immunomodulation. Given the ease of acquisition relative to other adult stem cells, considerable international effort is being invested toward indications for ASC therapies in the clinic, further developing the field of translational
  • T
    Preclinical Optimization of a Shelf-Ready, Human-Derived, Decellularized Allograft Adipose Matrix
    Tissue Engineering Part A Feb
    Authors: G Giatsidis, J Succar, A Haddad, G Lago, C Schaffer, X Wang, BK Schilling, E Chnari, H Matsumine; DP Orgill Autologous adipose tissue grafting is a popular strategy for soft tissue reconstruction; yet its clinical outcomes are often suboptimal. Lack of metabolic and architectural support at recipient sites affects the capacity of cellularized autologous grafts to survive after transplantation. Allograft adipose matrices (AAMs) are composed of extracellular matrices of adipose tissue. They can provide critical biophysical cues and create a supportive microenvironment for autologous graft survival. Using murine models, we have optimized the in vivo use of an injectable AAM obtained from human cadaveric tissue and processed to remove
  • T
    Adipose Stem Cells Enhance Nerve Regeneration and Muscle Function in a Peroneal Nerve Ablation Model
    Tissue Engineering Part A May
    Authors: JA Passipieri, J Dienes, J Frank, J Glazier, A Portel, KP Venkatesh, JM Bliley, D Grybowski, BK Schilling, KG Marra, GJ Christ Severe peripheral nerve injuries have devastating consequences on the quality of life in affected patients, and they represent a significant unmet medical need. Destruction of nerve fibers results in denervation of targeted muscles, which, subsequently, undergo progressive atrophy and loss of function. Timely restoration of neural innervation to muscle fibers is crucial to the preservation of muscle homeostasis and function. The goal of this study was to evaluate the impact of addition of adipose stem cells (ASCs) to polycaprolactone (PCL) nerve conduit guides on peripheral nerve repair and functional musc
  • S
    Comparison of Clinically Relevant Adipose Preparations on Articular Chondrocyte Phenotype in a Novel In Vitro Co-Culture
    Stem Cells and Development Oct
    Authors: LE Kokai, J Chen, D Wang, S Wang, FM Egro, BK Schilling, H Sun, A Ejaz, JP Rubin, JA Gusenoff, N Vo, K Onishi, and G Sowa Abstract: Adipose therapeutics, including isolated cell fractions and tissue emulsifications, have been explored for osteoarthritis (OA) treatment; however, the optimal preparation method and bioactive tissue component for healing has yet to be determined. This in vitro study compared the effects of adipose preparations on cultured knee chondrocytes. De-identified human articular chondrocytes were co-cultured with adipose preparations for 36 or 72 h. Human adipose tissues were obtained from abdominal panniculectomy procedures and processed using three different techniques: enzymatic digestion to release stromal
  • M
    Adipose-Derived Stem Cells Delay Muscle Atrophy after Peripheral Nerve Injury in the Rodent Model
    Muscle Nerve Jan
    Authors: BK Schilling & MA Schusterman, D Kim; AJ Repko, KC Klett; GJ Christ; KG Marra Introduction: Injuries to peripheral nerves cause distal muscle atrophy. The effects of adipose‐derived stem cell (ASC) injections into a muscle after injury were examined. Methods: A 1.5 cm defect in the rat sciatic nerve was created, resulting in gastrocnemius muscle atrophy. The nerve defect was repaired with autograft; DiR‐labeled ASCs were injected into the gastrocnemius immediately postoperatively. Quantitation of gross musculature and muscle fiber area, cell survival, fibrosis, lipid deposition, inflammation, and reconstructive responses were investigated. Results: ASCs were identified in the muscle at 6 weeks, where injections showed increased mu
  • T
    Design and Fabrication of a 3D-Printed Perfusion Device for Tissue Engineering Applications
    Tissue Engineering Part A Mar
    Authors: BK Schilling, K Lamberti, MJ Snowden, K Byrd, JS Baker, C Komatsu, MG Solari, KG Marra Tissue decellularization for generating extracellular matrices has become a staple of regenerative medicine in the recent decades, extending from the research setting to clinical usage. Although methods and protocols for tissue decellularization are abundant throughout the literature, they can be time intensive and typically require specific overhead in terms of equipment. To reduce these barriers to entry, a functional and reproducible prototype of a tissue infusion/perfusion device (TIPD) has been designed and fabricated using three-dimensional printed parts in conjunction with commercially available components. This TIPD forms a system compos
  • P
    Clinical Evaluation of an off-the-shelf allogeneic matrix for Soft Tissue Reconstruction
    PRS Global Open Jan
    Authors: LE Kokai, WN Sivak, BK Schilling, A Karunamurthy, FM Egro, MA Schusterman, DM Minteer, P Simon, JP Rubin Background: Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix (AAM) grafted into the pannus of presurgical abdominoplasty patients 3 or 6 months before scheduled surgery. This is the first report of a longitudinal histologic analysis of AAM in clinical use. Methods: Ten healthy patients undergoing elective abdominoplasty were recruited to receive AAM before surgery. Enrolled subjects were rand
  • S
    Adipose stem cells for peripheral nerve engineering
    Scientific Principles of Adipose Stem Cells Sep
    Authors: BK Schilling, GE Panagis, JS Baker, KG Marra Abstract: US healthcare expenditures remain in the hundreds of billions of dollars for treating peripheral nerve injury (PNI) every year, and therapies that advance the standard of care are critically necessary. Further, there is a profound socioeconomic impact resulting from PNI, as four of every 10 individuals experiencing these injuries do not return to work 1 year postoperatively owing to residual complications. As the prevalence and acceptance of clinical cellular therapies continue to increase, cell-based treatments that complement or augment current care for nerve injury are being introduced. The use of adipose-derived stem cells (ASCs) may be the ideal candidate for such investi
  • A
    Improved Testing and Design of Intubation Boxes During the COVID-19 Pandemic
    Annals of Emergency Medicine Sep
    Authors: DM Turer & CH Good, BK Schilling, RW Turer, NR Karlowsky, LA Dvoracek, H Ban, JS Chang, JP Rubin Study objective: Throughout the coronavirus disease 2019 pandemic, many emergency departments have been using passive protective enclosures (“intubation boxes”) during intubation. The effectiveness of these enclosures remains uncertain. We sought to quantify their ability to contain aerosols using industry standard test protocols. Methods: We tested a commercially available passive protective enclosure representing the most common design and compared this with a modified enclosure that incorporated a vacuum system for active air filtration during simulated intubations and negative-pressure isolation. We evaluated the enclosures by usi
  • J
    Biodegradable Silk Catheters for the Delivery of Therapeutics across Anatomical Repair Sites
    Journal of Biomedical Materials Research Part B Apr
    Authors: J Brown, L Tozzi, BK Schilling, A Kelmendi-Doko, A Truong, MJ Rodriguez, ES Gil, R Sucsy, J Valentin, B Philips, KG Marra, JP Rubin, DL Kaplan Biodegradable silk catheters for the delivery of therapeutics are designed with a focus on creating porous gradients that can direct the release of molecules away from the implantation site. Though suitable for a range of applications, these catheters are designed for drug delivery to transplanted adipose tissue in patients having undergone a fat grafting procedure. A common complication for fat grafts is the rapid reabsorption of large volume adipose transplants. In order to prolong volume retention, biodegradable catheters can be embedded into transplanted tissue to deliver nutrients, gro
This is a community-created genome.